F Garrido
Overview
Explore the profile of F Garrido including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
237
Citations
2372
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez-Gonzalez M, Garcia-Guinea J, Laborda F, Garrido F
Sci Total Environ
. 2015 Jul;
536:268-278.
PMID: 26218566
Thallium (Tl) and its compounds are toxic to biota even at low concentrations but little is known about Tl concentration and speciation in soils. An understanding of the source, mobility,...
2.
Gomez-Gonzalez M, Serrano S, Laborda F, Garrido F
Sci Total Environ
. 2014 Sep;
500-501:23-33.
PMID: 25217741
The formation of scorodite is an important mechanism for the natural attenuation of arsenic in a wide range of environments. It is dumped on site by metallurgical industries to minimize...
3.
Del Campo A, Carretero J, Munoz J, Zinchenko S, Ruiz-Cabello F, Gonzalez-Aseguinolaza G, et al.
Cancer Gene Ther
. 2014 Jun;
21(8):317-32.
PMID: 24971583
Optimal tumor cell surface expression of human leukocyte antigen (HLA) class I molecules is essential for the presentation of tumor-associated peptides to T-lymphocytes. However, a hallmark of many types of...
4.
Carretero R, Gil-Julio H, Vazquez-Alonso F, Garrido F, Castineiras J, Cozar J
Actas Urol Esp
. 2013 Dec;
38(3):192-9.
PMID: 24315763
Context And Objective: To analyze the influence of different alterations in human leukocyte antigen class I molecules (HLA I) in renal cell carcinoma, as well as in bladder and prostate...
5.
Garrido G, Rabasa A, Garrido C, Lopez A, Chao L, Garcia-Lora A, et al.
Oncogene
. 2013 Aug;
33(24):3129-39.
PMID: 23975426
To define the molecular basis of secondary resistance to epidermal growth factor receptor (EGFR)-specific antibodies is crucial to increase clinical benefit in patients. The limited access to posttreatment tumor samples...
6.
Del Campo A, Carretero J, Aptsiauri N, Garrido F
Tissue Antigens
. 2012 Feb;
79(3):147-54.
PMID: 22309256
The dynamic interaction between the host immune system and growing cancer has been of central interest to the field of tumor immunology over the past years. Recognition of tumor-associated antigens...
7.
Rodriguez-Jorda M, Garrido F, Garcia-Gonzalez M
J Hazard Mater
. 2009 Nov;
175(1-3):762-9.
PMID: 19932561
This study evaluates the potential use of four industrial by-products (phosphogypsum (PG), red gypsum (RG), sugar foam (SF), and ashes from biomass combustion (ACB)), applied at two rates in single...
8.
Saenz-Lopez P, Gouttefangeas C, Hennenlotter J, Concha A, Maleno I, Ruiz-Cabello F, et al.
Tissue Antigens
. 2009 Nov;
75(2):110-8.
PMID: 19912575
A total of 93 frozen primary renal cell carcinoma (RCC) samples and 31 frozen samples of corresponding normal renal tissue were analyzed for human leukocyte antigen (HLA) class I and...
9.
Rodriguez-Jorda M, Garrido F, Garcia-Gonzalez M
J Hazard Mater
. 2009 Nov;
175(1-3):328-35.
PMID: 19883978
Four industrial by-products (phosphogypsum, PG; red gypsum, RG; sugar foam, SF and ashes from the combustion of biomass, ACB) were evaluated as possible amendments for reducing the leachability and bioavailability...
10.
Del Campo A, Aptsiauri N, Mendez R, Zinchenko S, Vales A, Paschen A, et al.
Scand J Immunol
. 2009 Jul;
70(2):125-35.
PMID: 19630918
Here we report a successful use of a non-replicating adenovirus expressing the wild-type human beta2m gene in recovery of normal human leucocyte antigen (HLA) class I expression in beta2m-null cancer...